Boston Strategic Partners supports SAGE Therapeutics in the creation of an article titled “Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial”

(Boston,  June 2017) - Boston Strategic Partners supported SAGE Therapeutics in the creation of an article recently published in The Lancet online. The article titled “Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial” was a Phase 2, double-blind,…

BSP authors seven abstracts for ISPOR, one nominated as a Research Presentation Award Finalist

Boston Strategic Partners, Inc has authored seven abstracts that were accepted to be presented at the ISPOR Conference in Boston from May 20th-24th. The seven abstracts being presented are: Antibiotic Utilization, Treatment Outcomes, and Economic Impact in Pneumonia Patients: Retrospective…

Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD

March 2017 – Boston Strategic Partners, Inc. co-authored article “Cost Savings from Reduced Hospitalizations with Use of Home Noninvasive Ventilation for COPD” has been published in the March 2017 Issue of Value in Health, the Journal of the International Society…